column
Establishment of Care System for Hemophilia in China: Current Status and Future Prospect
YANG Renchi
2022, 1(4): 365-369. DOI: 10.12376/j.issn.2097-0501.2022.04.001
Abstract FullText HTML PDF
Establishment and Evolution of China National Hemophilia Registry
XUE Feng, YANG Renchi
2022, 1(4): 370-374. DOI: 10.12376/j.issn.2097-0501.2022.04.002
Abstract FullText HTML PDF
Current Status and Discussion of Hemophilia Aid System
CHENG Yan, FANG Yunhai, ZHANG Xinsheng
2022, 1(4): 375-379. DOI: 10.12376/j.issn.2097-0501.2022.04.003
Abstract FullText HTML PDF
Development and Application of Comprehensive Evaluation System in the Treatment of Children with Hemophilia in China
YAO Wanru, ZHANG Jishui, WU Runhui
2022, 1(4): 380-385. DOI: 10.12376/j.issn.2097-0501.2022.04.004
Abstract FullText HTML PDF
Status and Prospect of Gene Therapy for Hemophilia
DAI Xinyue, ZHANG Lei
2022, 1(4): 386-390. DOI: 10.12376/j.issn.2097-0501.2022.04.005
Abstract FullText HTML PDF
Complement Inhibitors in Rare Diseases
YUE Cai, DU Yali, HUANG Yangyu, CHEN Limeng, GUAN Yuzhou, HAN Bing
2022, 1(4): 391-399. DOI: 10.12376/j.issn.2097-0501.2022.04.006
Abstract FullText HTML PDF
The Progress in Research in Hereditary Thrombotic Thrombocytopenic Purpura in Children
FU Lingling, WU Runhui
2022, 1(4): 400-406. DOI: 10.12376/j.issn.2097-0501.2022.04.007
Abstract FullText HTML PDF
A Young Hemophilia Patient with Advanced Hemophilic Arthritis and HIV Infection
CAI Huacong, FENG Bin, CAO Wei, LIU Shufen, YUAN Tao, ZHANG Yan, LI Kuixing, ZHAO Yongqiang, WANG Shujie
2022, 1(4): 407-412. DOI: 10.12376/j.issn.2097-0501.2022.04.008
Abstract FullText HTML PDF
Skin Rash as the First Manifestation of Pediatric Chronic Neutrophilic Leukemia
ZHOU Yabin, DUAN Ruoyu, YAO Jiafeng, QIN Maoquan, DENG Jianghong, XU Zigang, WU Runhui
2022, 1(4): 413-419. DOI: 10.12376/j.issn.2097-0501.2022.04.009
Abstract FullText HTML PDF
Expert Consensus on Assessment for Rehabilitation and Treatment of Musculoskeletal Complications of Hemophilia in China
Hemophilia Treatment Center Collaborative Network of China, China Alliance for Rare Diseases, Hemophilia Subcommittee
2022, 1(4): 420-427. DOI: 10.12376/j.issn.2097-0501.2022.04.010
Abstract FullText HTML PDF
Chinese Expert Consensus on Pharmacokinetics Guided Treatment for Hemophilia A
Hemophilia Treatment Center Collaborative Network of China
2022, 1(4): 428-434. DOI: 10.12376/j.issn.2097-0501.2022.04.011
Abstract FullText HTML PDF
A Case Report of Cyclic Thrombocytopenia with Periodic Anemia
WANG Qi, WANG Zi, HAN Bing, CHEN Miao
2022, 1(4): 435-439. DOI: 10.12376/j.issn.2097-0501.2022.04.012
Abstract FullText HTML PDF
Four Cases of the Rare Skin Manifestation: Monoclonal-Proteinemia
JIN Xianghong, XU Junqing, YANG Chen, ZHU Tienan, ZHUANG Junling
2022, 1(4): 440-445. DOI: 10.12376/j.issn.2097-0501.2022.04.013
Abstract FullText HTML PDF
A Case of Chronic Myelomonocytic Leukemia: the Onset of which was Manifestedby Hypokalemia and Hypocalcemia
HAN Weimin, CHANG Xiaoli, HU Ronghua, SUN Wanling
2022, 1(4): 446-448. DOI: 10.12376/j.issn.2097-0501.2022.04.014
Abstract FullText HTML PDF
Practical Guidance for Ultrasonic Evaluation of Hemophilic Arthropathy
GUO Xinjuan, DING Xiaoling, LI Dongshuang, LI Jun
2022, 1(4): 449-455. DOI: 10.12376/j.issn.2097-0501.2022.04.015
Abstract FullText HTML PDF
A Case of Hemophilia B with Abdominal and Pelvic Pseudotumor
ZHANG Jing, JU Mankai, ZHANG Kemin, CHEN Lingling, WANG Yuhua, ZHANG Lei, YANG Renchi, XUE Feng
2022, 1(4): 456-460. DOI: 10.12376/j.issn.2097-0501.2022.04.016
Abstract FullText HTML PDF
Current Development Status and Consideration for Rare Hemorrhagic Disease Drugs
TANG Ling, ZOU Limin, DU Yu, QI Yueli, XIANG Meiyi, YANG Zhimin
2022, 1(4): 461-467. DOI: 10.12376/j.issn.2097-0501.2022.04.017
Abstract FullText HTML PDF
Current Situation and Prospect of Pharmacoeconomic Evaluation of Hemophilia in China
LI Shunping, DOU Lei, FANG Yunhai
2022, 1(4): 468-473. DOI: 10.12376/j.issn.2097-0501.2022.04.018
Abstract FullText HTML PDF
Development and Utilization of "One-Stop Finance Service" forRelief Fund for Hemophilia Patients
YE Changxiong, SUN Jing
2022, 1(4): 474-478. DOI: 10.12376/j.issn.2097-0501.2022.04.019
Abstract FullText HTML PDF
RSS Email alert